Z
Zia Rehman
Researcher at East Carolina University
Publications - 5
Citations - 111
Zia Rehman is an academic researcher from East Carolina University. The author has contributed to research in topics: Medicine & Genome-wide association study. The author has an hindex of 2, co-authored 3 publications receiving 61 citations.
Papers
More filters
Journal ArticleDOI
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis
Christopher J. Rhodes,Ken Batai,Marta Bleda,Matthias Haimel,Laura Southgate,Marine Germain,Michael W. Pauciulo,Charaka Hadinnapola,Jurjan Aman,Barbara Girerd,Amit Arora,Jo Knight,Ken B. Hanscombe,Jason H. Karnes,Marika Kaakinen,Henning Gall,Anna Ulrich,Lars Harbaum,Inês Cebola,Jorge Ferrer,Katie A. Lutz,Emilia M. Swietlik,Ferhaan Ahmad,Philippe Amouyel,Stephen L. Archer,Rahul G. Argula,Eric D. Austin,David B. Badesch,Sahil Bakshi,Christopher Barnett,Raymond L. Benza,Nitin Y. Bhatt,Harm Jan Bogaard,Charles D. Burger,Murali M. Chakinala,Colin Church,John G Coghlan,Robin Condliffe,Paul A. Corris,Cesare Danesino,Stéphanie Debette,C. Gregory Elliott,Jean M. Elwing,Mélanie Eyries,Terry Fortin,Andre Franke,Robert P. Frantz,Adaani E. Frost,Joe G.N. Garcia,Stefano Ghio,Hossein Ardeschir Ghofrani,J. Simon R. Gibbs,John B. Harley,Hua He,Nicholas S. Hill,Russel Hirsch,Arjan C. Houweling,Luke Howard,D. Dunbar Ivy,David G. Kiely,James R. Klinger,Gabor G. Kovacs,Tim Lahm,Matthias Laudes,Rajiv D. Machado,Robert V. MacKenzie Ross,Keith Marsolo,Lisa J. Martin,Shahin Moledina,David Montani,Steven D. Nathan,Michael Newnham,Andrea Olschewski,Horst Olschewski,Ronald J. Oudiz,Willem H. Ouwehand,Andrew J. Peacock,Joanna Pepke-Zaba,Zia Rehman,Ivan M. Robbins,Dan M. Roden,Erika B. Rosenzweig,Ghulam Saydain,Laura Scelsi,Robert Schilz,Werner Seeger,Christian M. Shaffer,Robert W. Simms,Marc A. Simon,Olivier Sitbon,Jay Suntharalingam,Haiyang Tang,Alexander Y. Tchourbanov,Thenappan Thenappan,Fernando Torres,Mark Toshner,Carmen M. Treacy,Anton Vonk Noordegraaf,Quinten Waisfisz,Anna K. Walsworth,Robert E. Walter,John Wharton,R. James White,Jeffrey Wilt,Stephen J. Wort,Delphine Yung,Allan Lawrie,Marc Humbert,Florent Soubrier,David-Alexandre Trégouët,Inga Prokopenko,Richard Kittles,Stefan Gräf,William C. Nichols,Richard C. Trembath,Ankit A. Desai,Nicholas W. Morrell,Martin R. Wilkins +117 more
TL;DR: Functional and epigenomic data indicate that the risk variants near SOX17 alter gene regulation via an enhancer active in endothelial cells that determined Pulmonary arterial hypertension risk variants determined haplotype-specific enhancer activity, and CRISPR-mediated inhibition of the enhancer reduced SoX17 expression.
Journal ArticleDOI
Granulocytic sarcoma of the male breast in acute myeloblastic leukemia with concurrent deletion of 5q and trisomy 8
TL;DR: A unique case of Granulocytic Sarcoma in a male, who presented to us with a painless right breast mass without any prior history of Leukemia, is described.
Nocturnal blood pressure assessment, an entity of high prognostic value, not utilized to its potential in clinical practice
Muhammad Umer Mukhtar,Sarmad Zahoor,Maryam Abid,Zia Rehman,Muhammad Aslam,Hafiz Muhammad Sajid Jehangir,Samar Firdous +6 more
TL;DR: In this paper , the authors provide an update on the proposed mechanisms underlying arrhythmogenesis in NAFLD and summarize the latest research findings in this field and recommend a comprehensive approach that includes treating the underlying liver condition and regular ECG monitoring to detect and address any potential cardiac complications.
Posted ContentDOI
Genetic determinants of risk and survival in pulmonary arterial hypertension
Christopher J. Rhodes,Ken Batai,Marta Bleda,Matthias Haimel,Laura Southgate,Marine Germain,Michael W. Pauciulo,Charaka Hadinnapola,Barbara Girerd,Amit Arora,Jo Knight,Ken B. Hanscombe,Jason H. Karnes,Marika Kaakinen,Henning Gall,Anna Ulrich,Lars Harbaum,Jurjan Aman,Inês Cebola,Jorge Ferrer,Ferhaan Ahmad,Philippe Amouyel,Stephen L. Archer,Rahul G. Argula,Eric D. Austin,David B. Badesch,Sahil Bakshi,Christopher Barnett,Raymond L. Benza,Nitin Y. Bhatt,Harm Jan Bogaard,Charles D. Burger,Murali M. Chakinala,Colin Church,John G Coghlan,Robin Condliffe,Paul A. Corris,Cesare Danesino,Stéphanie Debette,Gregory Elliott,Jean Elwing,Mélanie Eyries,Terry Fortin,Andre Franke,Robert P. Frantz,Adaani E. Frost,Joe G. N. Garcia,Stefano Ghio,Hossein Ardeschir Ghofrani,J. Simon R. Gibbs,John B. Harley,Hua He,Nicholas S. Hill,Russel Hirsch,Arjan C. Houweling,Luke Howard,D. Dunbar Ivy,David G. Kiely,James R. Klinger,Gabor G. Kovacs,Tim Lahm,Matthias Laudes,Katie A. Lutz,Rajiv D. Machado,Robert V. MacKenzie Ross,Keith Marsolo,Lisa J. Martin,Shahin Moledina,David Montani,Steven D. Nathan,Michael Newnham,Andrea Olschewski,Horst Olschewski,Ronald J. Oudiz,Willem H. Ouwehand,Andrew J. Peacock,Joanna Pepke-Zaba,Zia Rehman,Ivan M. Robbins,Dan M. Roden,E.B. Rosenzweig,Ghulam Saydain,Laura Scelsi,Robert Schilz,Werner Seeger,Christian M. Shaffer,Robert W. Simms,Marc A. Simon,Olivier Sitbon,Jay Suntharalingam,Emilia M. Swietlik,Haiyang Tang,Alexander Y. Tchourbanov,Thenappan Thenappan,Fernando Torres,Mark Toshner,Carmen M. Treacy,Anton Vonk-Noordegraaf,Quinten Waisfisz,Anna K. Walsworth,Robert E. Walter,John Wharton,James R. White,Jeffrey Wilt,Stephen J. Wort,Delphine Yung,Allan Lawrie,Marc Humbert,Florent Soubrier,David-Alexandre Trégouët,Inga Prokopenko,Richard Kittles,Stefan Gräf,William C. Nichols,Richard C. Trembath,Ankit A. Desai,Nicholas W. Morrell,Martin R. Wilkins +117 more
TL;DR: Functional and epigenomic data indicate that the risk variants near SOX17 alter gene regulation via an enhancer active in endothelial cells that stratifies PAH patients for survival following diagnosis, with implications for future therapeutic trial design.
Journal ArticleDOI
Non-Adherence Factors Associated with the Use of Rivaroxaban Among Patients with Deep Venous Thromboembolism: A Single Center Observational Study
TL;DR: In this paper , an observational longitudinal study was conducted at the Department of Surgery, Aga Khan University & Hospital, Karachi between June 2022 to November 2022 to assess the rate and factors associated with non-adherence of Rivaroxaban in patients with deep venous thrombosis.